United States · FDA National Drug Code directory
Risedronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59762-0406_6015697f-84b2-49c4-b59a-87956261df64
- Product NDC
- 59762-0406
- Form
- TABLET, FILM COATED
- Composition / generic term
- Risedronate Sodium
- Labeler
- Mylan Pharmaceuticals, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20080422
- Source listing expiry
- 20271231
Source-listed ingredients
- RISEDRONATE SODIUM HEMIPENTAHYDRATE — 129 mg/1
- RISEDRONATE SODIUM MONOHYDRATE — 21 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TABLET, FILM COATED in 1 DOSE PACK (59762-0406-1) · 59762-0406-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →